Influence of non-alcoholic fatty liver disease on cardiovascular disease |
| |
Authors: | Ampuero Javier Romero-Gómez Manuel |
| |
Affiliation: | Unidad de Gestión Clínica de Enfermedades Digestivas, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Hospital Universitario de Valme, Universidad de Sevilla, Sevilla, España |
| |
Abstract: | Non-alcoholic fatty liver disease encompasses a spectrum ranging from simple steatosis to steatohepatitis without excess alcohol intake and is considered to be the hepatic manifestation of metabolic syndrome. Recent studies indicate that non-alcoholic fatty liver disease is closely related to cardiovascular disease, especially to thickening of the intima-media layer of the carotid artery, as the morphostructural manifestation of the presence of subclinical atheromatosis. Therefore, the correct management of non-alcoholic fatty liver disease would allow the natural history of both the liver disease and the atherosclerosis to be modified. |
| |
Keywords: | NAFLD, Non-alcoholic fatty liver disease (enfermedad por hígado graso no alcohólica) NASH, Non-alcoholic steatohepatitis (esteatohepatitis no alcohólica) HTA, Hipertensión arterial DM2, Diabetes mellitus tipo 2 RI, Resistencia a la insulina HOMA, Homeostasis Model Assessment LDL, Low density lipoprotein (lipoproteína de baja densidad) HDL, High density lipoprotein (lipoproteína de alta densidad) VLDL, Very low density lipoprotein (lipoproteína de muy baja densidad) FFA, Free fatty acids (ácidos grasos libres) ATGL, Adipocyte TG hydrolase (lipasa adiposa de triglicéridos) PCR, Proteína C reactiva PAI-1, Plasmino gen activator inhibitor-1 (inhibidor del activador del plasminógeno-1) APOC3, Apolipoproteína C-III PNPLA3, Patatin-like phospholipase domain-containing 3 |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|